Drug firm Hetero has launched a bloslmllar of Bevaclzumab. used In treating metastatic colorectal cancer (mCRC), under the brand name CIzumabTM'. The product has been approved by Drug Controller General of India (DCGI) and Is recommended as a first-line ... India Infoline, 3 weeks ago
Hetero launches biosimilar of cancer drug - The Hindu, 3 weeks ago
Hetero’s biosimilar cancer drug - Business Line, 4 weeks ago
More from: Money Today, NDTV...and 5 other sources
Hetero Drugs Ltd. has the launch of a biosimilar for Roche's Avastin® (bevacizumab) in India. Hetero is marketing the drug under the brand name CizumabTM as a treatment for metastatic colorectal cancer. Hetero's launch is the second release of an ...JD Supra, 2 weeks ago Second Avastin biosimilar launched in India FiercePharma, 3 weeks ago Hetero launches Avastin biosimilar in India Livemint.com, 3 weeks ago India biosim of bevacizumab launched FiercePharma, 1 month ago
In an explosion at Hetero Drugs unit at Nakkapalli in Visakhapatnam, one worker died on the spot and two were seriously injured, on Wednesday evening.The incident happened when the workers were cuttin...The Hindu, 1 month ago
What is Isobutyl formate? It is a colourless liquid used as a flavour and fragrance ingredient because of its sweet and slightly fruity odour. VISAKHAPATNAM: In yet another industrial mishap in Visakhapatnam, one contract worker was killed and ...New Indian Express, 1 month ago One worker killed in explosion at pharma unit The Freepress Journal, 1 month ago Worker killed in explosion at pharma unit Chandigarh Tribune, 1 month ago One killed in explosion at Pharma Unit United News of India, 1 month ago
Hetero Drugs Launches Biosimilar 'Bevacizumab' For The Treatment Of Metastatic Colorectal Cancer (mCRC) Under The Brand Name 'Cizumabtm'
/PRNewswire/ -- Hetero, one of India's leading generic pharmaceutical companies, today announces the launch of Biosimilar 'Bevacizumab' in India for the treatment of metastatic colorectal cancer (mCRC) under the brand name 'CizumabTM' The product ...BioSpace, 4 weeks ago Hetero launches biosimilar Bevacizumab for cancer India Infoline, 4 weeks ago Hetero Launches Biosimilar #Bevacizumab# for the Treatment of Metastatic Colorectal Cancer (mCRC) Under the Brand Name #Cizumab(TM)# Newswit.com, 3 weeks ago Hetero lança 'Bevacizumab' biossimilar para o tratamento de Cncer Colorretal Metastático (mCRC) com o nome de 'CizumabTM' Healthcare Dive, 3 weeks ago
One of the generic Indian pharmaceutical companies, Hetero Drugs has launched a biosimilar for the treatment of metastatic colorectal cancer (mCRC) in India. Advertisement The drug called as "Bevacizumab" has been approved by the Drug Controller General of ...Med India, 3 weeks ago
Roche is attempting to block any approval of a biosimilar label for India-based Hetero Drugs bevacizumab similar biologic. In April 2016, the Delhi High Court barred India-based biologicals specialist Biocon and US generics maker Mylan from using ...GaBi Online, 1 month ago Roche challenges India regulator on Avastin biosimilar FiercePharma, 2 months ago Lawyers for Roche, Biocon trade contempt charges in Herceptin biosim case FiercePharma, 6 days ago
Roche has filed a lawsuit against the Drug Controller General of India (DCGI) and Hetero Drugs to block the launch of biosimilars of Avastin, as reported The Economic Times Monday. People familiar with the matter specifically noted that Roche ...FirstWord Pharma, 2 months ago Roche continues generics battle with latest lawsuit over Avastin copies BioPharma Dive, 2 months ago
Cost of these drugs for consumers will come down on average by around 25 percent T he Government has announced a new cap on the prices of 56 vital medicines used for the treatment of diabetes, blood pressure, cancer and bacterial infections which ...Pharmacy Choice, 1 month ago NPPA cuts prices of major drugs by 25% Business Standard India, 1 month ago Prices of 56 drugs used in curing cancer, BP capped The Financial Chronicle, 1 month ago 56 key drugs set to get cheaper as NPPA caps prices Hindu Business Line, 1 month ago
Drug firm Zydus Cadila has inked a generic manufacturing pact with the Medicines Patent Pool for manufacturing global pharma major Bristol-Myers Squibb's daclatasvir tablets used in the treatment of Hepatitis C. Indian pharma firms Aurobindo, ...India Infoline, 2 weeks ago Lupin, 5 Other Pharma Firms Ink Licensing Pact With Medicines Patent Pool NDTV, 2 weeks ago 6 Indian pharma cos ink licensing pact with UN-backed MPP Business Standard, 2 weeks ago Indian pharma cos ink licensing pact with UN-backed MPP The Freepress Journal, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!